High-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaks
MetadataShow full item record
DescriptionDescription of a promising cholera vaccine resulting from a study conducted in Mali by the University of Maryland, Baltimore, School of Medicine's Center for Vaccine Development (CVD). The new single-dose, live-attenuated oral vaccine is licensed and manufactured by PaxVax under the name of Vaxchora.
KeywordUniversity of Maryland, Baltimore. Center for Vaccine Development (CVD)
University of Maryland, Baltimore. School of Medicine